홍태곤
#임상약리#임상시험#적정약물요법#치료적 약물 모니터링
|
학력
가톨릭대학교 의학과 학사(2005)
가톨릭대학교 의학과 석,박사 통합과정(2015)
가톨릭대학교 의학과 석,박사 통합과정(2015)
경력
2005-2006 가톨릭중앙의료원 인턴
2011-2015 서울성모병원 임상약리학과 전공의
2015-2016 삼성서울병원 임상약리학과 임상강사
2016-2017 세브란스병원 임상시험센터/임상약리학과 강사
2017-현재 세브란스병원 임상시험센터/임상약리학과 임상조교수
2011-2015 서울성모병원 임상약리학과 전공의
2015-2016 삼성서울병원 임상약리학과 임상강사
2016-2017 세브란스병원 임상시험센터/임상약리학과 강사
2017-현재 세브란스병원 임상시험센터/임상약리학과 임상조교수
논문
Lee WY, Oh ES, Cui M, Kim CO, Lim Y, Kim H, Park H, Yoon S, Park MS, Hong T. Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects. Transl Clin Pharmacol. 2020 Mar; 28(1): 55?65
Lee HW, Park JY, Hong T, Park MS, Ahn SH. Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic HBV Infection.Clin Gastroenterol Hepatol. 2019 Oct 4. pii: S1542-3565(19)31089-4
Kim D, Park MS, Yoo BW, Hong T, Park SJ, Kim CO. The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male. Drug Des Devel Ther. 2019 Sep 3;13:3151-3159
Kim S, Hong T, Ko JW, Huh W, Kim JR. Comparison of the Pharmacokinetic-Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers. BioDrugs. 2019 Feb;33(1):101-11
Choi C, Yoo BW, Kim CO, Hong T, Jin BH, Seo KS, Jang JY, Park MS.Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers. Drug Des Devel Ther. 2018 Aug 12:2381-2387
Bae SH, Park WS, Han S, Park GJ, Lee J, Hong T, Jeon S, Yim DS. Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans. Korean J Physiol Pharmacol. 2018 May;22(3):321-329
Park J, Kim CO, Jin BH, Yang S, Park MS, Hong T. Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers. Transl Clin Pharmacol. 2017 Dec;25(4):202-208
Yang S, Noh H, Hahn J, Jin BH, Min KL, Bae SK, Kim J, Park MS, Hong T, Wi J, Chang MJ. Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation. Sci Rep. 2017 Nov;24;7(1):16276
Kim CO, Jeon S, Han S, Hong T, Park MS, Yoon YR, Yim DS, Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis. Transl Clin Pharmacol. 2017 Mar;25(1):43-51
Park WS, Han S, Lee J, Hong T, Won J, Lim Y, Lee K, Byun HY, Yim DS. Use of a Target-Mediated Drug Disposition Model to Predict the Human Pharmacokinetics and Target Occupancy of GC1118, an Anti-epidermal Growth Factor Receptor Antibody. Basic Clin Pharmacol Toxicol. 2017 Mar;120(3):243-249
Hong T, Han S, Lee J, Jeon S, Yim DS. Comparison of oral absorption models for pregabalin: usefulness of transit compartment model. Drug Des Devel Ther. 2016 Dec;10:3995-4003
Lee HW, Park JY, Hong T, Park MS, Ahn SH. Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic HBV Infection.Clin Gastroenterol Hepatol. 2019 Oct 4. pii: S1542-3565(19)31089-4
Kim D, Park MS, Yoo BW, Hong T, Park SJ, Kim CO. The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male. Drug Des Devel Ther. 2019 Sep 3;13:3151-3159
Kim S, Hong T, Ko JW, Huh W, Kim JR. Comparison of the Pharmacokinetic-Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers. BioDrugs. 2019 Feb;33(1):101-11
Choi C, Yoo BW, Kim CO, Hong T, Jin BH, Seo KS, Jang JY, Park MS.Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers. Drug Des Devel Ther. 2018 Aug 12:2381-2387
Bae SH, Park WS, Han S, Park GJ, Lee J, Hong T, Jeon S, Yim DS. Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans. Korean J Physiol Pharmacol. 2018 May;22(3):321-329
Park J, Kim CO, Jin BH, Yang S, Park MS, Hong T. Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers. Transl Clin Pharmacol. 2017 Dec;25(4):202-208
Yang S, Noh H, Hahn J, Jin BH, Min KL, Bae SK, Kim J, Park MS, Hong T, Wi J, Chang MJ. Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation. Sci Rep. 2017 Nov;24;7(1):16276
Kim CO, Jeon S, Han S, Hong T, Park MS, Yoon YR, Yim DS, Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis. Transl Clin Pharmacol. 2017 Mar;25(1):43-51
Park WS, Han S, Lee J, Hong T, Won J, Lim Y, Lee K, Byun HY, Yim DS. Use of a Target-Mediated Drug Disposition Model to Predict the Human Pharmacokinetics and Target Occupancy of GC1118, an Anti-epidermal Growth Factor Receptor Antibody. Basic Clin Pharmacol Toxicol. 2017 Mar;120(3):243-249
Hong T, Han S, Lee J, Jeon S, Yim DS. Comparison of oral absorption models for pregabalin: usefulness of transit compartment model. Drug Des Devel Ther. 2016 Dec;10:3995-4003
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.